Askel Healthcare

COPLA® — a 3D biodegradable scaffold implant that regenerates cartilage in weight-bearing joints, targeting knee pain from cartilage damage and prevention of osteoarthritis. Founded 2017 by Anne Marie Haaparanta (biomaterials research background); pilot clinical trial running in three Finnish and one Estonian hospital, EU/US market authorisation targeted for 2028.

The row

Sector

Medtech & Digital Health

Stage

Pre-revenue — No sales yet

Location

Tampere

Founded

2017

Research origin

Tampere Univ. + Univ. of Helsinki

Business ID

2818058-4 · Finnish trade register

Funding

~€8M raised (€6M seed + ~€2M share issue 10/2025) + €4M non-dilutive

Links

Where this sits on the map

Askel Healthcare is one of 33 companies in Medtech & Digital Health. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗